1 results match your criteria: "B.C. (Lano); the University of British Columbia Southern Medical Program[Affiliation]"
False-negative sentinel lymph node biopsy for melanoma: a single-surgeon experience.
Can J Surg
September 2024
From the Department of Surgical Oncology, BC Cancer-Sindi Ahluwalia Hawkins Centre, Kelowna, B.C. (Downey, Baliski); the Cancer Surveillance and Outcomes, BC Cancer, Vancouver, B.C. (DeVries); the Department of Pathology, Kelowna General Hospital, Kelowna, B.C. (Lano); the University of British Columbia Southern Medical Program, Kelowna, B.C. (Baliski)
Background: The status of the regional lymph node basin is of prognostic importance in patients with melanoma, making the performance of sentinel lymph node biopsies (SLNBs) a key component of patient care management, particularly with the advent of immunotherapy for adjuvant treatment. The primary goal of our study was to assess the false-negative rate of SLNBs among patients with melanoma.
Methods: We conducted a retrospective review of patients with melanoma undergoing SLNB by a single surgeon between Jan.